+ All Categories
Home > Documents > ROS/NO/O2 1a. Introduction: Background

ROS/NO/O2 1a. Introduction: Background

Date post: 09-Feb-2016
Category:
Upload: karik
View: 23 times
Download: 0 times
Share this document with a friend
Description:
ROS/NO/O2 1a. Introduction: Background. ENDOTHELIAL FUNCTION OF SUBDERMAL MICROVESSELS, PLASMA ADMA AND ROS MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 1 OR EARLY ESSENTIAL HYPERTENSION. Dan Wang, M.D., Ph.D. Christopher Wilcox, M.D., Ph.D. Sven Strangaard , Ph.D. - PowerPoint PPT Presentation
Popular Tags:
8
ROS/NO/O2 1a. Introduction: Background
Transcript
Page 1: ROS/NO/O2 1a. Introduction: Background

ROS/NO/O2

1a. Introduction: Background

Page 2: ROS/NO/O2 1a. Introduction: Background
Page 3: ROS/NO/O2 1a. Introduction: Background
Page 4: ROS/NO/O2 1a. Introduction: Background
Page 5: ROS/NO/O2 1a. Introduction: Background
Page 6: ROS/NO/O2 1a. Introduction: Background

• Dan Wang, M.D., Ph.D.• Christopher Wilcox, M.D., Ph.D.• Sven Strangaard, Ph.D.• Shakil Aslam, M.D.

ENDOTHELIAL FUNCTION OF SUBDERMAL MICROVESSELS, PLASMA ADMA AND ROS MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 1 OR EARLY ESSENTIAL HYPERTENSION

Page 7: ROS/NO/O2 1a. Introduction: Background
Page 8: ROS/NO/O2 1a. Introduction: Background

CONCLUSIONS

• Humans with essential hypertension or CKD-1 have:– reduced

microvascular EDRF and NOS

– increased circulating ADMA

– oxidative stress


Recommended